OR WAIT null SECS
November 02, 2022
Next year's "FDA Voices" series will cover core topics FDA staff are prioritizing.
October 02, 2022
The 1VQ papers advocate for the idea that certain post-approval changes should be streamlined and expedited.
September 02, 2022
While the cost of certain medicines are alarmingly high, they can be considered a bargain measured against a lifetime of traditional costs.
August 02, 2022
How can we fix the quality manufacturing issues that come with product shortages?
July 02, 2022
Systemic inefficiencies in the pharmaceutical industry undermine problem-solving efforts.
June 02, 2022
AI could provide solutions to critical manufacturing inefficiencies.
May 01, 2022
Spring has returned, and with it comes INTERPHEX.
April 02, 2022
Advances in pharmaceutical neuroscience present an opportunity for pharmaceutical companies to stay ahead of the curve.
March 02, 2022
Reducing US dependency on overseas pharma manufacturing may prove critical in navigating supply chain disruptions.
February 02, 2022
Busy is good for business.